Global Hot Flashes Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hot Flashes Treatment Market Research Report 2024
Hot flashes are typically characterized by sudden mild or intense body heat because of the changes occurrence by hormones. This occurs due to decreased level of estrogens. The phenomenon of host flashes in men, young women, or pregnant ladies is projected because of medical conditions that may also disrupt the body’s ability to regulate temperature. It is mostly seen in menopause conditions. The hot flashes are generally belief to be lasting for 30 minutes. The common symptoms associated with hot flashes include feeling of anxiety, rapid heartbeat, perspiration on upper body, red and blotchy skin and palpitations.
According to Mr Accuracy reports’s new survey, global Hot Flashes Treatment market is projected to reach US$ 15520 million in 2029, increasing from US$ 12200 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hot Flashes Treatment market research.
Factors such as rising incidence of vasomotor symptoms during menopause and technological advancements in developing new therapeutic agents are driving the market growth. For example, according to an article published in the June 2022 issue of Women's Health, an online survey was conducted in the United Kingdom between 19 and 26 May 2021 to assess attitudes, years of knowledge and symptoms. According to observations, 68.9% of women experienced mood swings during menopause, 68.3% experienced brain fog, and 66.8% experienced fatigue symptoms. In addition, other psychological problems, including irritability, poor concentration, poor memory, lack of motivation, decreased self-confidence and anxiety, can affect their quality of life.
According to an article published in September 2021 in the International Journal of Reproductive Biomedicine, it has been observed that around 50-85% of women worldwide experience menopausal heat symptoms. Furthermore, according to the same source, the prevalence of menopausal hot flash symptoms is reported to be highest in Western countries and lowest in Asian countries. This is expected to spur the demand for hormonal and non-hormonal therapies for the treatment of menopausal symptoms, thereby boosting the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hot Flashes Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla Inc
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
Boehringer Ingelheim International GmbH
Sanofi
AstraZeneca
GSK Plc
Pfizer Inc
Novartis AG
Mylan N.V
Hisamitsu Pharmaceutical Co.,Inc
Merck & Co., Inc
TherapeuticsMD, Inc
Lilly
Emcure Pharmaceuticals Limited
Bayer AG
Novo Nordisk Corporation
Segment by Type
Oral
Parenteral
Hospital
Specialist Clinic
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Hot Flashes Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Hot Flashes Treatment market is projected to reach US$ 15520 million in 2029, increasing from US$ 12200 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hot Flashes Treatment market research.
Factors such as rising incidence of vasomotor symptoms during menopause and technological advancements in developing new therapeutic agents are driving the market growth. For example, according to an article published in the June 2022 issue of Women's Health, an online survey was conducted in the United Kingdom between 19 and 26 May 2021 to assess attitudes, years of knowledge and symptoms. According to observations, 68.9% of women experienced mood swings during menopause, 68.3% experienced brain fog, and 66.8% experienced fatigue symptoms. In addition, other psychological problems, including irritability, poor concentration, poor memory, lack of motivation, decreased self-confidence and anxiety, can affect their quality of life.
According to an article published in September 2021 in the International Journal of Reproductive Biomedicine, it has been observed that around 50-85% of women worldwide experience menopausal heat symptoms. Furthermore, according to the same source, the prevalence of menopausal hot flash symptoms is reported to be highest in Western countries and lowest in Asian countries. This is expected to spur the demand for hormonal and non-hormonal therapies for the treatment of menopausal symptoms, thereby boosting the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hot Flashes Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla Inc
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
Boehringer Ingelheim International GmbH
Sanofi
AstraZeneca
GSK Plc
Pfizer Inc
Novartis AG
Mylan N.V
Hisamitsu Pharmaceutical Co.,Inc
Merck & Co., Inc
TherapeuticsMD, Inc
Lilly
Emcure Pharmaceuticals Limited
Bayer AG
Novo Nordisk Corporation
Segment by Type
Oral
Parenteral
Segment by Application
Hospital
Specialist Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Hot Flashes Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices